A detailed history of Robeco Institutional Asset Management B.V. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 2,065,496 shares of RDY stock, worth $29.5 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,065,496
Previous 2,069,231 0.18%
Holding current value
$29.5 Million
Previous $158 Million 4.09%
% of portfolio
0.33%
Previous 0.34%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$75.41 - $84.21 $281,656 - $314,524
-3,735 Reduced 0.18%
2,065,496 $164 Million
Q2 2024

Jul 22, 2024

BUY
$68.26 - $76.19 $6.45 Million - $7.2 Million
94,511 Added 4.79%
2,069,231 $158 Million
Q1 2024

Apr 24, 2024

BUY
$67.36 - $77.59 $16.8 Million - $19.3 Million
249,340 Added 14.45%
1,974,720 $145 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $23 Million - $25 Million
357,481 Added 26.13%
1,725,380 $120 Million
Q4 2023

Feb 08, 2024

SELL
$64.27 - $69.9 $19.6 Million - $21.3 Million
-305,227 Reduced 18.24%
1,367,899 $1.73 Billion
Q3 2023

Oct 23, 2023

BUY
$61.9 - $72.77 $13.5 Million - $15.9 Million
218,605 Added 15.03%
1,673,126 $112 Million
Q2 2023

Jul 24, 2023

BUY
$53.34 - $63.11 $21.3 Million - $25.2 Million
399,384 Added 37.85%
1,454,521 $91.8 Million
Q1 2023

May 03, 2023

BUY
$51.63 - $56.93 $8.87 Million - $9.78 Million
171,875 Added 19.46%
1,055,137 $60.1 Million
Q4 2022

Feb 06, 2023

BUY
$51.15 - $57.45 $45.2 Million - $50.7 Million
883,262 New
883,262 $45.7 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.37B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.